论文部分内容阅读
目的探讨急性白血病患者检测超敏C-反应蛋白(hs-CRP)水平的临床意义。方法随机选取2012年7月至2015年3月急性白血病患者96例为白血病组,同时选取96例正常健康者为体检组,观察并记录体检组以及白血病组患者治疗前后的hs-CRP水平,并进行比较分析。结果治疗前白血病组hs-CRP阳性率(93.75%)高于体检组(0),差异有统计学意义(P<0.05);白血病组hs-CRP水平高于体检组,差异有统计学意义(P<0.05);治疗后白血病组96例患者的症状均完全缓解,治疗后白血病组hs-CRP水平低于治疗前,差异有统计学意义(P<0.05);急性髓系白血病组阳性率和hs-CRP水平均高于急性淋巴细胞白血病组,差异有统计学意义(P<0.05)。结论 hs-CRP的表达水平对急性白血病的诊治具有非常重要的指导作用,值得在临床推广使用。
Objective To investigate the clinical significance of detecting hs-CRP in patients with acute leukemia. Methods Ninety-six patients with acute leukemia from July 2012 to March 2015 were selected as leukemia group. 96 normal subjects were selected as the test group. The levels of hs-CRP in the patients in the examination group and the leukemia group were observed and recorded before and after treatment For comparative analysis. Results The positive rate of hs-CRP in leukemia group (93.75%) before treatment was higher than that in the test group (0) (P <0.05). The hs-CRP level in leukemia group was higher than that in the control group (the difference was statistically significant P <0.05). After treatment, the symptoms of 96 patients in leukemia group were completely relieved. After treatment, the hs-CRP level in leukemia group was lower than that before treatment (P <0.05); the positive rate in acute myeloid leukemia group hs-CRP levels were higher than acute lymphoblastic leukemia group, the difference was statistically significant (P <0.05). Conclusion The expression level of hs-CRP has a very important guiding role in the diagnosis and treatment of acute leukemia, and it is worth to be used clinically.